- Home
- CLFD vs VSTM Comparison
CLFD vs VSTM Comparison
Compare CLFD & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLFD
- VSTM
- Stock Information
- Founded
- CLFD 1979
- VSTM 2010
- Country
- CLFD United States
- VSTM United States
- Employees
- CLFD N/A
- VSTM N/A
- Industry
- CLFD Telecommunications Equipment
- VSTM Biotechnology: Pharmaceutical Preparations
- Sector
- CLFD Utilities
- VSTM Health Care
- Exchange
- CLFD Nasdaq
- VSTM Nasdaq
- Market Cap
- CLFD 426.1M
- VSTM 359.9M
- IPO Year
- CLFD N/A
- VSTM 2012
- Fundamental
- Price
- CLFD $34.31
- VSTM $7.17
- Analyst Decision
- CLFD Strong Buy
- VSTM Strong Buy
- Analyst Count
- CLFD 3
- VSTM 9
- Target Price
- CLFD $46.67
- VSTM $13.63
- AVG Volume (30 Days)
- CLFD 96.0K
- VSTM 1.4M
- Earning Date
- CLFD 05-08-2025
- VSTM 05-20-2025
- Dividend Yield
- CLFD N/A
- VSTM N/A
- EPS Growth
- CLFD N/A
- VSTM N/A
- EPS
- CLFD N/A
- VSTM N/A
- Revenue
- CLFD $178,209,000.00
- VSTM $10,000,000.00
- Revenue This Year
- CLFD $8.64
- VSTM $7.68
- Revenue Next Year
- CLFD $16.53
- VSTM $605.06
- P/E Ratio
- CLFD N/A
- VSTM N/A
- Revenue Growth
- CLFD N/A
- VSTM N/A
- 52 Week Low
- CLFD $23.78
- VSTM $2.10
- 52 Week High
- CLFD $44.83
- VSTM $13.52
- Technical
- Relative Strength Index (RSI)
- CLFD 75.17
- VSTM 57.92
- Support Level
- CLFD $30.34
- VSTM $6.35
- Resistance Level
- CLFD $31.68
- VSTM $8.00
- Average True Range (ATR)
- CLFD 1.20
- VSTM 0.67
- MACD
- CLFD 0.65
- VSTM 0.01
- Stochastic Oscillator
- CLFD 78.46
- VSTM 46.93
About CLFD Clearfield Inc.
Clearfield Inc mainly designs, manufactures, and distributes fiber protection, fiber management and fiber delivery solutions for communications networks. It provides a range of products including copper assemblies, cassettes, box enclosures, fiber connectors, frames, microduct, terminals, vaults, pedestal inserts, FieldSmart, WaveSmart, and CraftSmart. The company has a global presence with the majority of the revenue derived from the United States. The company has two reportable segments namely Clearfield segment and Nestor cables segment. The majority of revenue is derived from Clearfield segment.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.